Can-Fite BioPharma American Depositary Shares
CANF
5 hedge funds and large institutions have $254K invested in Can-Fite BioPharma American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
17% less funds holding
Funds holding: 6 → 5 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
73% less capital invested
Capital invested by funds: $929K → $254K (-$674K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$130K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$61.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$610K |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$103K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$37K |
| 4 |
Morgan Stanley
New York
|
-$27.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $104K | -$27.6K | -52 | -17% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $101K | +$130K | +246 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $48K | +$61.5K | +116 | New |
|
|
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.1K | – | – | – |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| – | -$610K | -1,059 | Closed |
|
|
MIH
6
Meitav Investment House
Bene-Beraq,
Israel
| – | -$103K | -170 | Closed |
|
|
TSS
7
Two Sigma Securities
New York
| – | -$37K | -65 | Closed |
|
CANF Hedge Fund Activity: Q3 2019 in Review
5 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q3 2019, worth a combined $254K — down 73% from $929K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CANF and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $130K. The largest seller was Sabby Management, exiting entirely with an estimated $610K sold.
- 5 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q3 2019, down from 6 in Q2 2019.
- Funds reported $254K of Can-Fite BioPharma American Depositary Shares stock for Q3 2019, down 73% quarter-over-quarter.
- 2 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q3 2019 and 3 closed out, a net change of -1 holder.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q3 2019 was Susquehanna International Group, an estimated $130K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q3 2019 was Sabby Management, an estimated $610K sold.
Based on aggregated 13F filings for Q3 2019.